Skip to search formSkip to main contentSkip to account menu

Human Immunodeficiency Virus Protease Inhibitor [EPC]

Known as: HIV PI, Human Immunodeficiency Virus Protease Inhibitor, HIV Protease Inhibitor (HIV PI) 
National Institutes of Health

Related topics

Related topics

4 relations
HIV InfectionsHIV Protease InhibitorsHIV Protease Inhibitors [MoA]Protease Inhibitor [EPC]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
Pharmacokinetic characterization of a human immunodeficiency virus protease inhibitor, saquinavir, during ethanol intake in rats
Throughout therapeutic drug monitoring of human immunodeficiency virus (HIV) protease inhibitors in HIV‐infected patients, it was… 
1999
1999
Biocatalytic synthesis of chiral intermediates for antiviral and antihypertensive drugs
The chiral intermediate (1S,2R) [3-chloro-2-hydroxy-1-(phenylmethyl)propyl] carbamic acid, 1,1-dimethylethyl ester 2a was… 
1997
1997
In vitro and ex vivo anti-human immunodeficiency virus (HIV) activities of a new water-soluble HIV protease inhibitor, R-87366, containing (2S,3S)-3-amino-2-hydroxy-4-phenylbutanoic acid.
In a series of compounds containing (2S,3S)-3-amino-2-hydroxy-4-phenylbutanoic acid (AHPBA), a transitionstate mimetic, R-87366… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)